找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Human Tumour Xenografts in Anticancer Drug Development; Benjamin Winograd,Michael Peckham,Herbert Michael Conference proceedings 1988 Spr

[復(fù)制鏈接]
樓主: 浮淺
41#
發(fā)表于 2025-3-28 14:41:01 | 只看該作者
Screening of Analogs in Human Ovarian Cancer Xenograftshylmelamine at maximum tolerated doses. As for cisplatin analogs tested in two lines, carboplatin was shown to be similar in efficacy to cisplatin, followed by iproplatin, JM-40 and TN0-38; tetraplatin and spiroplatin were considered less active. Experimental data correlated well with clinical findi
42#
發(fā)表于 2025-3-28 20:16:15 | 只看該作者
43#
發(fā)表于 2025-3-28 23:27:13 | 只看該作者
Activity of Six New Drugs in Head and Neck Cancer Xenograftsmum tolerated doses. 5-Aza-2′-deoxycytidine (5-aza-dCyd), a nucleoside analogue, was active in 1 , moderately active in another and inactive in 3 tu mour lines. Activity was dose-schedule dependent, indicating that new drugs ought to be tested in at least 2 dose-schedules. Trimetrexate, a new folate
44#
發(fā)表于 2025-3-29 06:13:34 | 只看該作者
https://doi.org/10.1007/978-3-642-73252-2Antigen; biochemistry; carcinoma; interferon; transplantation
45#
發(fā)表于 2025-3-29 10:41:56 | 只看該作者
ESO Monographshttp://image.papertrans.cn/h/image/429563.jpg
46#
發(fā)表于 2025-3-29 12:08:02 | 只看該作者
47#
發(fā)表于 2025-3-29 16:39:36 | 只看該作者
48#
發(fā)表于 2025-3-29 23:34:29 | 只看該作者
Bioinformatics - A Student‘s Companiont home and in school. Hypothalamic impairments complicate day-to-day life—high pain tolerance, temperature dysregulation, sleepiness, and constant drive to eat. Pituitary deficiencies of growth hormone and GnRH require skilled endocrine care throughout the lifespan. Children with PWS are at risk for
49#
發(fā)表于 2025-3-30 01:55:30 | 只看該作者
Bingcheng Wang,Chang Jingdentification, creation, and initial classification of reusable application patterns while retrieval, adaptation, and storage reuse tasks with case-based reasoning support are treated briefly at the conclusion as an introductory information about launching research.
50#
發(fā)表于 2025-3-30 05:43:25 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 16:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
通州市| 凌海市| 日照市| 安阳市| 江津市| 丹凤县| 惠州市| 汉川市| 哈尔滨市| 邹城市| 克什克腾旗| 舞钢市| 阿尔山市| 海伦市| 金塔县| 双桥区| 南昌市| 娄烦县| 建始县| 朝阳区| 孟津县| 桂东县| 综艺| 临高县| 扎兰屯市| 韶山市| 延津县| 湖南省| 岑巩县| 赤城县| 大埔县| 灵川县| 新丰县| 青海省| 鸡泽县| 长治县| 上虞市| 社旗县| 合江县| 永登县| 绥阳县|